Lexicon Pharmaceuticals
LXRX
#6659
Rank
A$0.97 B
Marketcap
A$2.31
Share price
-3.05%
Change (1 day)
213.98%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): A-$0.30

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.28. In 2024 the company made an earnings per share (EPS) of A-$0.93 an increase over its 2023 EPS that were of A-$1.16.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.30-67.47%
2024A-$0.93-20%
2023A-$1.1631.15%
2022A-$0.89-0%
2021A-$0.8910.91%
2020A-$0.80-145.08%
2019A$1.77-206.09%
2018A-$1.67-5.74%
2017A-$1.77-10.95%
2016A-$1.992640%
2015A-$0.07256-96.34%
2014A-$1.98-2.53%
2013A-$2.03-9.09%
2012A-$2.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$25.79-9,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$7.95-2,984.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$62.57-22,794.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.47 2,973.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$9.14-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.73 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.09 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.64-1,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$111.32 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA